Glaukos

Glaukos beats path to FDA after eye implant trials hit goals
Glaukos beats path to FDA after eye implant trials hit goals
Fierce Pharma
Glaukos
eye implant
travoprost intraocular implant
glaucoma
ocular hypertension
FDA
Flag link:
Glaukos pays iVeena $10M for eye drop vision loss candidate
Glaukos pays iVeena $10M for eye drop vision loss candidate
Fierce Pharma
Glaukos
iVeena
IVMED-80
keratoconus
Flag link:
25 Most Attractive Medtech M&A Targets in 2022
25 Most Attractive Medtech M&A Targets in 2022
Medical Devices and Diagnostics Industry
Medtech
devices
M&A
AtriCure
Axonics
Cardiovascular Systems
Conmed
Glaukos
Inari Medical
InMode
Inspire Medical Systems
iRhythm Technologies
NeuroPace
Nevro
NuVasive
OrthoPediatrics
Paragon 28
Penumbra
Pulmonx
Shockwave Medical
SI-BONE
Silk Road Medical
Staar Surgical
Tandem Diabetes
Treace Medical Concepts
TELA Bio
ViewRay
Flag link:
10 of the Most Anticipated New Medical Devices
10 of the Most Anticipated New Medical Devices
Medical Devices and Diagnostics Industry
devices
Medtech
Senseonics
Eversense XL
Insulet
Omnipod 5
Globus Medical
xcelsius 3D Imaging System
Glaukos
iStent Infinite
DexCom
G7
Zimmer Biomet
Persona IQ
Abbott Labs
Amulet
Evo Visian
Medtronic
Guardian 4
SurModics
SurVeil
Flag link:
Glaukos touts 5-year study of glaucoma stents
Glaukos touts 5-year study of glaucoma stents
Mass Device
Glaukos
iStent
glaucoma
eye health
devices
Flag link:
Glaukos Keeps Its Eye on the Prize at J.P. Morgan
Glaukos Keeps Its Eye on the Prize at J.P. Morgan
Medical Devices and Diagnostics Industry
JPMHC 2019
Glaukos
glaucoma
devices
Flag link:
Glaucoma Device Makers See a Bright Future Ahead
Glaucoma Device Makers See a Bright Future Ahead
Medical Devices and Diagnostics Industry
MIGS
glaucoma
devices
Ivantis
Glaukos
Flag link:
Glaukos Corp Completed Its IPO This Week; Now Trades Near $28 Mark
Glaukos Corp Completed Its IPO This Week; Now Trades Near $28 Mark
Yahoo/Benzinga
Glaukos
IPOs
ophthalmic
glaucoma
Flag link:
Biotechs line up for a busy week of IPOs
Biotechs line up for a busy week of IPOs
Fierce Biotech
biotech
IPOs
Seres Therapeutics
Glaukos
Pieris
Catabasis
Flag link:
FDA OKs Glaukos' iStent for cataract surgery
FDA OKs Glaukos' iStent for cataract surgery
FDA
Glaukos
iStent
stent
surgical
Flag link: